Mariner’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-78,363
Closed -$1.98M 3717
2026
Q1
$1.98M Buy
78,363
+1,406
+2% +$35.9K ﹤0.01% 1529
2025
Q4
$1.96M Buy
76,957
+1,160
+2% +$29.7K ﹤0.01% 1515
2025
Q3
$1.94M Buy
75,797
+5,691
+8% +$144K ﹤0.01% 1461
2025
Q2
$1.77M Buy
70,106
+4,546
+7% +$113K ﹤0.01% 1418
2025
Q1
$1.64M Buy
65,560
+2,953
+5% +$73K ﹤0.01% 1349
2024
Q4
$1.54M Buy
62,607
+3,109
+5% +$77.8K ﹤0.01% 1362
2024
Q3
$1.53M Buy
59,498
+792
+1% +$20K ﹤0.01% 1339
2024
Q2
$1.44M Buy
58,706
+10,445
+22% +$255K ﹤0.01% 1284
2024
Q1
$1.2M Buy
48,261
+30,783
+176% +$763K ﹤0.01% 1395
2023
Q4
$441K Buy
+17,478
New +$417K ﹤0.01% 2030

Other funds holding IBDX

Mariner's IBDX Position: Q2 2026 in Review

Mariner sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q2 2026, closing a stake of 78,363 shares — an estimated $1.98M sold.

Mariner first reported a position in IBDX in Q4 2023 and held it in 10 quarters. The position peaked at $1.98M in Q1 2026. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Mariner reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q2 2026 after selling out during the quarter.
  • Mariner sold 78,363 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $1.98M.
  • Mariner first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and held it in 10 quarters.
  • Mariner's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $1.98M in Q1 2026.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.